Patents by Inventor Balbino Jose Alarcon Sanchez

Balbino Jose Alarcon Sanchez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TETRAHYDROISOQUINOLINE COMPOUNDS
    Publication number: 20220380357
    Abstract: The present invention relates to a novel class of tetrahydroisoquinoline compounds of formula I and to compositions comprising the same. The compounds and compositions of the present invention can be used as medicaments in the treatment of cancer.
    Type: Application
    Filed: July 9, 2020
    Publication date: December 1, 2022
    Inventors: Miguel VEGA GARCÍA, Pedro CAMPOS MUELAS, Esther CARRASCO ROMERO, Asunción BURGUETE PÉREZ, Patricia GÓMEZ GUTIÉRREZ, Juan Jesús PÉREZ GONZÁLEZ, Ángel MESSEGUER PEYPOCH, Balbino José ALARCÓN SÁNCHEZ
  • Tetrahydroisoquinoline compounds
    Patent number: 11466012
    Abstract: The present invention relates to a novel class of tetrahydroisoquinoline compounds of formula I and to compositions comprising the same. The compounds and compositions of the present invention can be used as medicaments in the treatment of cancer.
    Type: Grant
    Filed: January 10, 2019
    Date of Patent: October 11, 2022
    Assignee: ALLINKY BIOPHARMA
    Inventors: Miguel Vega García, Pedro Campos Muelas, Esther Carrasco Romero, Asunción Burguete Pérez, Patricia Gómez Gutiérrez, Juan Jesús Pérez González, Ángel Messeguer Peypoch, Balbino José Alarcón Sánchez, Irene Azahara Arellano Rojo
  • TETRAHYDROISOQUINOLINE COMPOUNDS
    Publication number: 20200369671
    Abstract: The present invention relates to a novel class of tetrahydroisoquinoline compounds of formula I and to compositions comprising the same. The compounds and compositions of the present invention can be used as medicaments in the treatment of cancer.
    Type: Application
    Filed: January 10, 2019
    Publication date: November 26, 2020
    Inventors: Miguel VEGA GARCÍA, Pedro CAMPOS MUELAS, Esther CARRASCO ROMERO, Asunción BURGUETE PÉREZ, Patricia GÓMEZ GUTIÉRREZ, Juan Jesús PÉREZ GONZÁLEZ, Ángel MESSEGUER PEYPOCH, Balbino José ALARCÓN SÁNCHEZ, Irene Azahara ARELLANO ROJO
  • INHIBITORS OF T CELL RECEPTOR AND USES THEREOF
    Publication number: 20190231745
    Abstract: The present invention relates to selective inhibitors of TCR, and methods of using the same.
    Type: Application
    Filed: December 19, 2018
    Publication date: August 1, 2019
    Inventor: Balbino Jose Alarcon Sanchez
  • Chromene derivatives
    Patent number: 9120764
    Abstract: Derivates of chromene of formula I, where the meanings for the various substituents are as indicated in the description. These compounds are useful as inhibitors of TCR-Nck interaction in T lymphocytes.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: September 1, 2015
    Assignee: Consejo Superior de Investigaciones Cientificas
    Inventors: Balbino Jose Alarcon Sanchez, Angel Messeguer Peypoch, Antonio Morreale De Leon, Aldo Jorge Borroto Revuelta, Irene Azahara Arellano Rojo, Almudena Perona Requena, Esther Carrasco Romero
  • CHROMENE DERIVATIVES
    Publication number: 20140005247
    Abstract: Derivates of chromene of formula I, where the meanings for the various substituents are as indicated in the description. These compounds are useful as inhibitors of TCR-Nck interaction in T lymphocytes.
    Type: Application
    Filed: July 8, 2011
    Publication date: January 2, 2014
    Applicant: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
    Inventors: Balbino Jose Alarcon Sanchez, Angel Messeguer Peypoch, Antonio Morreale De Leon, Aldo Jorge Borroto Revuelta, Irene Azahara Arellano Rojo, Almudena Perona Requena, Esther Carrasco Romero